Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

16.10
+1.439.75%
Pre-market: 16.04-0.0600-0.37%08:07 EDT
Volume:20.89M
Turnover:330.58M
Market Cap:18.45B
PE:-11.10
High:16.22
Open:14.70
Low:14.67
Close:14.67
Loading ...

Why Teva Pharmaceuticals Industries Ltd. (TEVA) Crashed Yesterday

Insider Monkey
·
03 Jan

Vantage Drilling International Ltd. Announces Creation of Totalenergies and Vantage Joint Venture Entity

GlobeNewswire
·
02 Jan

Teva Pharmaceutical Industries Ltd (TEVA) Ends Trading Week Defying Market Bloodbath

Insider Monkey
·
28 Dec 2024

Why Teva Pharmaceuticals Industries (TEVA) Skyrocketed?

Insider Monkey
·
24 Dec 2024

Teva put volume heavy and directionally bearish

TIPRANKS
·
24 Dec 2024

Weekly Winners | Teva Soars 34%; Birkenstock Rallies 10%; Palantir, Li Auto Gain 6%

Tiger Newspress
·
22 Dec 2024

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

Insider Monkey
·
21 Dec 2024

Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals

Zacks
·
20 Dec 2024

Jim Cramer on Teva Pharmaceutical Industries (TEVA): A Game-Changer for Intractable Disease Treatments?

Insider Monkey
·
19 Dec 2024

Stock Track | Teva Pharmaceutical Soars 5% on Positive Study Data For Investigational IBD Drug

Stock Track
·
19 Dec 2024

Teva Pharmaceutical Stock Positioned for Even Better Performance in 2025, UBS Says

MT Newswires Live
·
19 Dec 2024

BofA Securities Raises Price Target on Teva Pharmaceutical Industries to $25 From $23, Keeps Buy Rating

MT Newswires Live
·
18 Dec 2024

Teva : Bofa Global Research Raises Price Objective to $25 From $23

THOMSON REUTERS
·
18 Dec 2024

SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study

Zacks
·
18 Dec 2024

Teva price target raised to $28 from $26 at UBS

TIPRANKS
·
18 Dec 2024

Strength Seen in Teva Pharmaceutical Industries (TEVA): Can Its 26.5% Jump Turn into More Strength?

Zacks
·
18 Dec 2024